Cargando…
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521092/ https://www.ncbi.nlm.nih.gov/pubmed/34663791 http://dx.doi.org/10.1038/s41408-021-00563-8 |
| _version_ | 1784584827289206784 |
|---|---|
| author | Wang, Di Mao, Xia Que, Yimei Xu, Menglei Cheng, Yuhang Huang, Liang Wang, Jue Xiao, Yi Wang, Wen Hu, Guang Zhang, Shangkun Zhang, Tongcun Li, Chunrui Zhou, Jianfeng |
| author_facet | Wang, Di Mao, Xia Que, Yimei Xu, Menglei Cheng, Yuhang Huang, Liang Wang, Jue Xiao, Yi Wang, Wen Hu, Guang Zhang, Shangkun Zhang, Tongcun Li, Chunrui Zhou, Jianfeng |
| author_sort | Wang, Di |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8521092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85210922021-10-18 Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy Wang, Di Mao, Xia Que, Yimei Xu, Menglei Cheng, Yuhang Huang, Liang Wang, Jue Xiao, Yi Wang, Wen Hu, Guang Zhang, Shangkun Zhang, Tongcun Li, Chunrui Zhou, Jianfeng Blood Cancer J Correspondence Nature Publishing Group UK 2021-10-18 /pmc/articles/PMC8521092/ /pubmed/34663791 http://dx.doi.org/10.1038/s41408-021-00563-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Wang, Di Mao, Xia Que, Yimei Xu, Menglei Cheng, Yuhang Huang, Liang Wang, Jue Xiao, Yi Wang, Wen Hu, Guang Zhang, Shangkun Zhang, Tongcun Li, Chunrui Zhou, Jianfeng Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy |
| title | Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy |
| title_full | Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy |
| title_fullStr | Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy |
| title_full_unstemmed | Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy |
| title_short | Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy |
| title_sort | viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-bcma car therapy |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521092/ https://www.ncbi.nlm.nih.gov/pubmed/34663791 http://dx.doi.org/10.1038/s41408-021-00563-8 |
| work_keys_str_mv | AT wangdi viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT maoxia viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT queyimei viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT xumenglei viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT chengyuhang viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT huangliang viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT wangjue viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT xiaoyi viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT wangwen viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT huguang viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT zhangshangkun viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT zhangtongcun viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT lichunrui viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy AT zhoujianfeng viralinfectionreactivationduringlongtermfollowupinmultiplemyelomapatientswithantibcmacartherapy |